1. Allain P, Heudi O, Cailleux A, Le Bouil A, Larra F, Boisdron-Celle M, Gamelin E (2000) Early biotransformations of oxaliplatin after its intravenous administration to cancer patients. Drug Metab Dispos 28:1379
2. Allen J, Graham MA, Firth J, Woolfrey S, Greenslade D, Morrison JG, McDougall S, Ross P, Cunningham D (1998) Biotransformation and pharmacokinetics analysis of oxaliplatin in patients with advanced gastrointestinal cancer. Proc Am Assoc Cancer Res 39:159
3. Beal SL, Sheiner LB (1982) Estimating population kinetics. Crit Rev Biomed Eng 8:195
4. Cassidy J (2000) Review of oxaliplatin: an active platinum agent in colorectal cancer. Int J Clin Pract 54:399
5. Culy CR, Clemett D, Wiseman LR (2000) Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. Drugs 60:895